General
Preferred name
VALPROMIDE
Synonyms
Sanofi synthelabo brand of dipropylacetamide ()
Depamide ()
Dipropylacetamide ()
2-propylpentanamide ()
Valpramide ()
Depamide, Dipropylacetamide, 2-propylpentanamide ()
Valpromida ()
P&D ID
PD006915
CAS
2430-27-5
Tags
available
drug
Drug Status
experimental
approved
investigational
Max Phase
2.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
11
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMatrix
MedChem Express Bioactive Compound Library
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
29
Properties
(calculated by RDKit )
Molecular Weight
143.13
Hydrogen Bond Acceptors
1
Hydrogen Bond Donors
1
Rotatable Bonds
5
Ring Count
0
Aromatic Ring Count
0
cLogP
1.69
TPSA
43.09
Fraction CSP3
0.88
Chiral centers
0.0
Largest ring
0.0
QED
0.62
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
2-epoxide hydrolase
Limonene-1
epoxide hydrolase
HSV
Indication
epilepsy
MOA
epoxide hydolase inhibitor
Pathway
Anti-infection
Metabolic Enzyme/Protease
Source data
